# VivaChek Biotech (Hangzhou) Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vivachek-biotech-hangzhou-co

- Industry: Medical Devices & Equipment
- Headquarters: Hangzhou, China
- Website: www.vivachek.com
- Latest round: Series D (Jul 17, 2026)
- Investors on record: 4

## About

Based in Hangzhou, Zhejiang Province, China and founded in 2013, Hangzhou Vivachek Biotech Co., Ltd. is a medical technology company focused on point-of-care testing (POCT) diagnostics and healthcare information solutions. The company has been recognized as a National High-Tech Enterprise, Specialized and Sophisticated Enterprise, Little Giant Enterprise, and Hidden Champion Enterprise. In July 2026, it raised tens of millions of CNY in a series D funding round. VivaChek develops and manufactures a wide range of POCT diagnostic products used for rapid clinical testing and healthcare management applications. Its core business includes the development, production, and commercialization of point-of-care testing systems capable of delivering timely diagnostic results in hospitals, clinics, pharmacies, community healthcare centers, and home-care environments. The company's primary revenue is generated through the sale of POCT diagnostic devices, testing systems, and related medical products supplied to healthcare institutions, diagnostic laboratories, pharmacies, and healthcare providers. The company will use the latest funding for its continued technological iteration, new product R&D and implementation, and global market expansion, aiming to further solidify its position in innovative POCT and digital chronic disease healthcare.

## Funding rounds

- Series D, Jul 17, 2026 — Goldport Capital
- Series A, Mar 5, 2019 — Lujiazui (Zhejiang) Assets Management
- Series B, Sep 1, 2016 — GTJA Investment Group
- Angel, Mar 21, 2016 — Langtaosha Venture Capital

## Investors

- Langtaosha Venture Capital (https://capitalatlas.ai/funds/langtaosha-venture-capital) — Angel
- GTJA Investment Group (https://capitalatlas.ai/funds/gtja-investment-group) — Series B
- Lujiazui (Zhejiang) Assets Management (https://capitalatlas.ai/funds/lujiazui-zhejiang-assets-management) — Series A
- Goldport Capital (https://capitalatlas.ai/funds/goldport-capital) — Series D